Objectives. Infection with oncogenic human papillomaviruses (HPV) is a prerequisite 2 for the development of cervical cancer. In many cases of cervical cancer and all cervical 3 cancer derived cell lines oncogenic HPV DNA is found to be integrated, indicating the 4 importance of integration in disease development. In this study, 176 HPV 16 positive 5 precancerous cervical lesions were analyzed for the physical state of viral genome to 6 determine the sites of integration into a host cell DNA and to evaluate the incidence of the 7 integration in different stages of cervical lesions. 8
Introduction PCR amplification of E1/E2 gene of HPV 16 DNA 1
The E1/E2 PCR was performed according to Yoshinouchi et al. [17] and Lukaszuk et 2 al. [18] , who describe the protocols for E1 and E2 gene amplification, respectively. Briefly, 2 3 pairs of PCR primers were used: E1A (ATGTTACAGGTAGAAGGGCG; 
Statistical analysis 5
The results obtained by different methods were entered and processed manually into 6
Microsoft Excel on a personal computer. The differences between study groups were 7 evaluated by Chi-square ( 2 ) test (GraphPad Prism version 4.00 for Windows, GraphPad 8 Software, San Diego California USA), with p value under 0.05 being statistically significant. 9
Results

11
Using the DIPS method, 176 HPV 16 positive DNA samples from patients with 12 different grades of cervical neoplasia were analyzed. Using Sau3A I restriction enzyme, it was 13 impossible to determine the HPV genome state in all samples. Samples in which the analysis 14 with Sau3A I enzyme failed or gave undetermined result were additionally analyzed with TaqIf the HPV genome is present in the extrachromosomal form in the sample, DIPS PCR 17 should amplify DNA of expected size. Failure to amplify DNA or amplification of different 18 fragment size than expected suggests that the HPV genome might be integrated. To verify this 19 assumption such PCR products were sequenced. In 10 of 176 samples (5.7%), sequencing 20 confirmed the presence of only HPV DNA, even though the PCR product was of an unusual 21
size. It appears that those samples contained HPV 16 variants with internal rearrangements 22 and/or gain or loss of Sau3A I or Taq I restriction site (data not shown). Using the described 23 methods, the status of HPV genomes was determined in 146 of 176 (82.9%) samples, 8 ofwhich (5.5%) were shown to be integrated, 3 (2%) were shown to contain both 1 extrachromosomal and integrated forms, and the remaining 135 (92.5%) had 2 extrachromosomal HPV genomes. 3
Both Sau3A I and Taq I based DIPS assays failed to resolve the HPV genome status of 4 30 of 176 (17.1%) samples. In 23 of 30 samples, the amplification of large DIPS amplicons 5 was unsuccessful due to unknown reasons, but most likely because of the fragmentation 6 (degradation) of sample DNA as the short amplicons of E1/E2 PCR were successfully 7 obtained from those samples. In addition, in 7 of 30 samples, only some of all target large 8 DIPS amplicons were amplified and in 2 of those 7 samples there were amplicons suggesting 9 integration of HPV 16 DNA. However, the sequencing of the DIPS amplicons supposedly 10 containing human DNA sequences was unsuccessful, leaving those 7 samples with 11 inconclusive result, also. 12
The unsuccessful amplification of E1 and/or E2 genes indicates whether those genes 13 are disrupted because of the HPV genome integration into a host cell genome. In this study, 14 the E1/E2 PCR analysis has shown the presence of integration in 9 of 176 (5.1%) samples. In 15 8 of 9 (88.9%) E2 region was disrupted, with the remaining one (11.1%) sample having E1 16 region disrupted. 17
The combined integration results obtained with both methods, DIPS and E1/E2 PCR 18 reveal the integration in 13 of 176 (7.4%) samples. The discordance between the findings by the two methods, DIPS and E1/E2 PCR 1 (Table 3) is due to the fact that E1/E2 PCR cannot distinguish between mixed and 2 extrachromosomal viral genomes, and it cannot detect the integration event in samples where 3 the loss of viral DNA is not within regions covered by the PCR primers used in this study. 4 Thus, the three samples determined as mixed forms by DIPS PCR were detected as 5 extrachromosomal form by E1/E2 PCR. In addition, one sample that was classified as 6 integrated by DIPS PCR and extrachromosomal by E1/E2 PCR had a break in the viral DNA 7 that was not in the regions amplified by E1/E2 PCR primers (data not shown). Finally, two 8 samples classified as integrated by E1/E2 PCR did not give conclusive result with DIPS PCR. 9
The DIPS PCR method enabled the amplification of 11 (6.3%) fragments containing 10 viral and cellular DNA. In 6 of those samples both ends of cellular/viral junction amplicon 11 were successfully sequenced, while in 5 cases only one end of viral cellular/junction was 12 resolved, so the information about affected HPV and cellular genes and scope of deletions 13 was incomplete in those cases. Briefly, in 6 of 11 (54.5%) samples the integration was found 14 to occur within cellular genes and also in 6 of 11 (54.5%) samples within CFS (Table 4) . The E1/E2 PCR method is simple and easy to perform but it cannot be used for the 5 determination of the site of integration and it cannot distinguish between extrachromosomal 6
and mixed viral forms. Furthermore, this method does not detect integrated copies where the 7 loss of viral DNA is outside of regions covered with PCR primers that were used in this study. 8
These two issues were the main cause of discrepancy in the results obtained with both 9 methods, DIPS and E1/E2 PCR. 10
The DIPS PCR method is rather time consuming and laborious, however it allows 11 accurate determination of the site of integration in the human genome. On the other hand, the 12 method is not very suitable for determining the frequency of integration, since it did not give 13 us any conclusive result in 17.1% cases. For that reason, the results of both methods, DIPS 14 and E1/E2 PCR are presented herein. 15
These combined findings indicate that integration of HPV 16 DNA is not an early 16 event as Peitsaro et al. [26] and Gallo et al. [24] suggest, them having found 50% integratedApart from the frequency of integration, the main goal of this study was to determine 1 the sites of integration within human genome by using the DIPS PCR method. The HPV 16 2 integration found in this study was random as expected; it occurred once on chromosomes 2, 3 7 and 10 and twice on chromosomes 1, 11, 17 and 19, but on different parts of chromosomes 4 (Table 4 ). According to the majority of studies, the integration of HPV DNA is a random 5 event and the place of integration does not affect the progression of the disease [10] . 6 However, in this study HPV 16 integration occurred in many cases (54.5%) within CFS. This 7 result is in accordance with Thorland et al. [29] who found HPV 16 integrated in the CFS in 8 48% of their cases. Some authors consider that HPV integration in CFS, which are prone to 9 breaks and different types of rearrangements, is the result of their greater accessibility [10] .
myc, TP63, FANCC, hTERT and others, was not shown to affect the expression of thosesites were identified as targets of HPV integration in previous studies, and some of the 1 affected genes were linked to cervical, as well as other types of cancer. 2 Namely, 3 cases of HPV 16 integration within the fragile site FRA17B [10] have been 3 previously found in cervical cancer specimens and one of them was in the VMP1 gene [29] . 4 Furthermore, 5 integrations of HPV 18 in cervical cancer samples have been reported in the 5 same region (17q23) [10] . This indicates that HPV integrations within region 17q23 are more 6 frequent than chance would suggest, and potential disruption of the gene involved in 7 apoptosis might be implicated in cervical cancer progression. 8
The integration in 17q12 region was not in the fragile site, but was in proximity of the 9 TCF2 gene. As the 3'-end of the integrated fragment was not resolved it is possible that the 10 TCF2 gene is affected. The TCF2 protein is a transcription factor involved in the metabolism 11 of nucleic acids and nucleotides. It has been extensively studied, and one study indicates that 12 it could be involved in the development of ovarian cancer [30] . In addition, Wentzensen et al. 13
[10] also reported HPV16 to be integrated in this region (17q12) in one cervical cancer 14 sample. 15
The HPV 16 integration within PVRL gene might also have an impact on progression 16 of cancer. The PVRL1 is a transmembrane protein involved in cellular adhesion and Herpes
The integration in FRA2J (2q37.3 locus) was mapped in the proximity of the ILKAP 1 gene, which codes for a serine/threonine phosphatase from the phosphatase family PP2C. The 2 ILKAP protein interacts with integrin linked kinases (ILK), which regulate integrin cellular 3 signaling, and it is also associated with Wnt signaling pathway [38, 39] . There is no published 4 data on the HPV integration in this locus of the human genome, but again, some data suggest 5 that LOH of 2q might influence cervical cancerogenesis [40] . 6 The integration in FRA19B (19p13.11 locus) was found to be directly disrupting the 7 coding region of the CHERP gene, which codes for a ribonucleoprotein situated in the In case of the sample containing both, integrated and extrachromosomal forms of HPV 8 16 DNA, the integration occurred at the position 11p14.3, in the proximity of the FRA11D. 9
As there are no known genes in this region it is difficult to predict any changes due to the 10 viral integration. 11
The findings of this study show that HPV 16 genome integration is not an early event 12
in the progression of cervical disease, and that the preferential regions of integration are the 13 common fragile sites. This study also shows HPV genomes to often be integrated in or near 14 cellular genes. Since most of those genes could be involved in tumor progression, this 15
suggests that the site of integration might play a role in the rate and the nature of development 16 of cervical cancer. By investigating the sites of HPV DNA integration we might also get some 17 insight about cellular genes that may be involved in the progression of cervical cancer and 18 also potentially some other types of cancer. Further research is necessary to finally resolve the 19 timing and preferential sites of HPV integration. The real-time PCR on large number of 20 precancerous samples would easily resolve the timing issue, while the DIPS PCR analysis of 21 samples with integrated viral genome would answer whether there are indeed preferential 22 integration sites. In addition, since HPV integration status indicates high risk for development 23 and progression of cervical cancer, it should be considered for a diagnostic approach. In this 24 case also, a method based on real-time PCR that is less time consuming and informative forboth integrated and extrachromosomal states, as shown in this study to be common, would be 1 more appropriate. 2 3 
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